Unlimited Sciences, a not-for-profit research organization based in Denver, and the Johns Hopkins University Center for Psychedelic and Consciousness Research announced they are collaborating on a study of real-world uses and effects of psychedelic mushrooms (Psilocybin).
The study will ask Psilocybin users a series of validated questions before, during and after use. Psilocybin mushrooms have been shown in previous studies to help individuals struggling with depression and other behavioral health conditions. Researchers conducting the study aim to survey more than 1,000 participants, who will be asked to describe their state of mind and physical situation at up to six periods surrounding a planned dose of the mushrooms.
Johns Hopkins University has more than two decades of history researching Psilocybin, and in 2000 became the first organization in the United States to be approved for reinitiating research with Psilocybin in healthy, psychedelic-naïve volunteers.
"Research suggests these compounds produce remarkable experiences felt to be profoundly meaningful, with enduring positive changes in attitudes, moods, and behavior, years into the future," Unlimited Sciences board president Heather Jackson said in a news release. "By expanding this study to include far more examples of real-life usage and outcomes, we can continue to learn more and refine our research. A study of this type can direct future controlled clinical trials."